CSL Seqirus

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Novartis_Vaccines_and_Diagnostics
gptkbp:collaboratesWith health organizations
gptkbp:contributedTo global immunization efforts
gptkbp:employs over 1,000 people
gptkbp:founded 2015
gptkbp:hasPart clinical trials
product development team
quality assurance processes
manufacturing facilities
global distribution network
marketing team
research laboratories
regulatory affairs team
supply chain management team
Seqirus
regulatory compliance team
safety monitoring team
vaccine production facilities
gptkbp:headquarters gptkb:Parkville,_Australia
https://www.w3.org/2000/01/rdf-schema#label CSL Seqirus
gptkbp:industry biotechnology
gptkbp:isActiveIn community engagement
vaccine research
healthcare_partnerships
gptkbp:isDedicatedTo sustainable practices
gptkbp:isEngagedIn public health partnerships
vaccine development
public health advocacy
gptkbp:isFocusedOn gptkb:Australian_Securities_Exchange
pandemic preparedness
immunization strategies
vaccine supply chain
gptkbp:isHeadquarteredIn gptkb:Victoria,_Australia
gptkbp:isIncorporatedIn gptkb:Australia
gptkbp:isInvolvedIn clinical research
global health initiatives
vaccine education programs
vaccine safety research
vaccine policy development
gptkbp:isKnownFor collaborative research efforts
commitment to public health
high-quality vaccines
seasonal influenza vaccines
gptkbp:isPartOf gptkb:CSL_Group
gptkbp:isRecognizedFor innovation in vaccines
safety and efficacy of vaccines
gptkbp:isSupportedBy scientific community
government health agencies
gptkbp:offers influenza vaccines
gptkbp:operatesIn global market
gptkbp:parentCompany gptkb:CSL_Limited
gptkbp:produces seasonal flu vaccines
gptkbp:researchAndDevelopment focus on vaccine innovation
gptkbp:serves public health needs
gptkbp:specializesIn vaccines
gptkbp:supports vaccine access initiatives
gptkbp:website www.cslseqirus.com